Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Dow futures little changed as investors await corporate earnings

Published 17/04/2023, 09:00 pm
Updated 17/04/2023, 09:00 pm
© Reuters

By Noreen Burke

Investing.com -- U.S. stock futures pointed to a flat open on Wall Street on Monday as investors awaited corporate earnings reports, including more bank results as well as remarks from Federal Reserve officials which could offer insights into the future path of interest rates.

At 06:42 ET (10:42 GMT), the Dow futures contract was up 20 points or 0.1%, S&P 500 futures were flat, and Nasdaq 100 futures dipped 16 points or 0.1%.

Wall Street ended lower on Friday as mixed economic data cemented expectations for another rate hike from the Fed in May, dampening investor enthusiasm after a series of big U.S. bank earnings kicked off first quarter earnings season.

While banking heavyweights including JPMorgan Chase (NYSE:JPM) benefitted from higher interest payments, focus will be on smaller banks that were at the center of last month's turmoil in the financial sector.

Major U.S. banks including Goldman Sachs Group (NYSE:GS), Bank of America (NYSE:BAC), Morgan Stanley (NYSE:MS) will report through the week, while Charles Schwab (NYSE:SCHW) and State Street (NYSE:STT) are among the financial companies reporting ahead of the open on Monday.

But investor focus may now turn to how more consumer discretionary companies are faring given persistently high inflation and the Fed's aggressive rate-hiking cycle.

Results from the likes of Netflix (NASDAQ:NFLX), Tesla (NASDAQ:TSLA), and Johnson & Johnson (NYSE:JNJ) this week could easily disrupt the optimism generated by Friday's strong bank numbers.

Several central bank policymakers including New York Fed President John Williams and Cleveland Fed President Loretta Mester are due to speak later in the week, with investors on the lookout for their assessment on the risk of a recession and when rate hikes may pause.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Stocks likely to be in focus include Prometheus Biosciences (NASDAQ:RXDX) which surged in premarket trade after Merck (NYSE:MRK) said it is buying the biotech company for about $10.8 billion.

Meanwhile, Dell Technologies (NYSE:DELL) shares slid after JPMorgan downgraded the PC maker to "neutral," while HP (NYSE:HPQ) moved higher after the brokerage upgraded its stock to "overweight."

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.